Summary
Updated Aug 30, 2026
Mette Kirstine Agger files SEC Form 4 reports at Lexeo Therapeutics, Inc. (LXEO). 2 SEC Form 4 filings on record going back to 2025, most recently on 29 June 2026.
Trading Pattern
InsiderAlpha's records for Mette Kirstine Agger go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Mette Kirstine Agger files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Richard Nolan Townsend - $656K of LXEO open-market activity in the last 12 months
- Narinder Pal Bhalla - $99K of LXEO open-market activity in the last 12 months
- Jose Manuel Otero - $79K of LXEO open-market activity in the last 12 months
- Louis Edward Tamayo - $41K of LXEO open-market activity in the last 12 months
- Tai Sandi See - $38K of LXEO open-market activity in the last 12 months
- Jenny Robertson - $37K of LXEO open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Mette Kirstine Agger?
Mette Kirstine Agger is a corporate insider of Lexeo Therapeutics, Inc. (LXEO). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mette Kirstine Agger submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Mette Kirstine Agger's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Mette Kirstine Agger and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial